Prevalence and Profile of Tapentadol Use in Patients Visiting a Drug De-addiction Center in Kashmir
Background: Misuse of prescription opioids has been a hazard lately with tapentadol being a recent addition to the list. Tapentadol is a schedule H1 opioid (Drugs and Cosmetics Rules, India), approved for the management of moderate-to-severe acute and chronic pain. Aims and Objectives: We examined t...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Wolters Kluwer Medknow Publications
2024-11-01
|
| Col·lecció: | Indian Journal of Social Psychiatry |
| Matèries: | |
| Accés en línia: | https://journals.lww.com/10.4103/ijsp.ijsp_12_23 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|